KOELIS
Antoine Leroy is the Founder and CEO of KOELIS, a rapidly expanding international MedTech company specializing in innovative image guidance systems for urologists, with operations in France, the USA, Germany, and Singapore since October 2006. Prior to establishing KOELIS, Antoine served as the Director of Research at PRAXIM medivision, where responsibilities included the design and development of computer-assisted surgical products for orthopaedics and urology. Antoine's experience also includes a role as a Research Engineer at TIMC-IMAG, focusing on image-guided surgery and advanced surgical planning techniques, culminating in a Ph.D. awarded with honors. Earlier in Antoine's career, an engineering position at INRIA involved creating realistic simulations for liver surgery. Antoine holds a Master of Science in Computer Engineering and a Ph.D. in Image Guided Surgery from reputable institutions.
KOELIS
KOELIS has assisted urologists and radiologists from around the world in their routine clinical practice since 2006, providing the latest technology for personalized prostate cancer planning and management, from biopsy to active surveillance and treatment. Focused on developing advanced, targeted and less invasive solutions, KOELIS is committed to creating and bringing to the market a new paradigm in prostate cancer care, where physicians can offer the most personalized answers to their patients, avoiding any under or overtreatment and preserving quality of life. Thanks to cutting-edge imaging tools like Trinity® cartographer, which combines multiple imaging modalities with full 3D ultrasound, any suspicious lesion is characterized in a detailed 3D prostate map, offering a comprehensive and multiparametric approach and enhancing diagnostic confidence. The team at KOELIS innovates every day in collaboration with world-renowned universities and hospitals to offer physicians new advancements in imaging and a greater field of view, a must-have in active surveillance and targeted treatment. Based in Grenoble and Princeton, KOELIS technology has been featured in more than 50 clinical publications and treats more than 300,000 patients worldwide, including patients in Europe, United States, Canada, Japan, Australia, South America and the Middle East.